210 related articles for article (PubMed ID: 29694948)
1. Baseline High-Sensitivity C-Reactive Protein Predicts Macrovascular and Microvascular Complications of Type 2 Diabetes: A Population-Based Study.
Aryan Z; Ghajar A; Faghihi-Kashani S; Afarideh M; Nakhjavani M; Esteghamati A
Ann Nutr Metab; 2018; 72(4):287-295. PubMed ID: 29694948
[TBL] [Abstract][Full Text] [Related]
2. Retinopathy and hypertension affect serum high-sensitivity C-reactive protein levels in Type 2 diabetic patients.
Tsunoda K; Arita M; Yukawa M; Ueyama M; Furuta M; Nakagawa T; Nanjo K; Sanke T
J Diabetes Complications; 2005; 19(3):123-7. PubMed ID: 15866055
[TBL] [Abstract][Full Text] [Related]
3. High-sensitivity C-reactive protein and coronary heart disease mortality in patients with type 2 diabetes: a 7-year follow-up study.
Soinio M; Marniemi J; Laakso M; Lehto S; Rönnemaa T
Diabetes Care; 2006 Feb; 29(2):329-33. PubMed ID: 16443882
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein as a marker of progression of carotid atherosclerosis in subjects with type 2 diabetes mellitus.
Pleskovič A; Letonja MŠ; Vujkovac AC; Nikolajević Starčević J; Gazdikova K; Caprnda M; Gaspar L; Kruzliak P; Petrovič D
Vasa; 2017 May; 46(3):187-192. PubMed ID: 28218562
[TBL] [Abstract][Full Text] [Related]
5. Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes.
Pu LJ; Lu L; Xu XW; Zhang RY; Zhang Q; Zhang JS; Hu J; Yang ZK; Ding FH; Chen QJ; Lou S; Shen J; Fang DH; Shen WF
Cardiovasc Diabetol; 2006 Dec; 5():27. PubMed ID: 17178005
[TBL] [Abstract][Full Text] [Related]
6. Is serum C-reactive protein concentration correlated with HbA1c and insulin resistance in Type 2 diabetic men with or without coronary heart disease?
Bahceci M; Tuzcu A; Ogun C; Canoruc N; Iltimur K; Aslan C
J Endocrinol Invest; 2005 Feb; 28(2):145-50. PubMed ID: 15887860
[TBL] [Abstract][Full Text] [Related]
7. Association of serum high-sensitivity C-reactive protein with metabolic control and diabetic chronic vascular complications in patients with type 2 diabetes.
Chuengsamarn S; Rattanamongkolgul S; Sittithumcharee G; Jirawatnotai S
Diabetes Metab Syndr; 2017; 11(2):103-108. PubMed ID: 27697536
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of high sensitivity C-reactive protein in three-vessel disease patients with and without type 2 diabetes.
Guo L; Lv H; Wang J; Zhang B; Zhu Y; Zhang X; Zhu H; Zhou X; Xia Y
Cardiovasc Diabetol; 2023 Apr; 22(1):91. PubMed ID: 37081535
[TBL] [Abstract][Full Text] [Related]
9. Association of C-reactive protein with body fat, diabetes and coronary artery disease in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-6).
Mohan V; Deepa R; Velmurugan K; Premalatha G
Diabet Med; 2005 Jul; 22(7):863-70. PubMed ID: 15975100
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: findings from the 1999-2004 NHANES.
Veeranna V; Zalawadiya SK; Panaich S; Patel KV; Afonso L
Int J Cardiol; 2013 Oct; 168(6):5156-61. PubMed ID: 24016543
[TBL] [Abstract][Full Text] [Related]
11. Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus.
Streja D; Cressey P; Rabkin SW
J Diabetes Complications; 2003; 17(3):120-7. PubMed ID: 12738395
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
13. Conflicting interactions of apolipoprotein A and high density lipoprotein cholesterol with microvascular complications of type 2 diabetes.
Aryan Z; Afarideh M; Ghajar A; Esteghamati S; Esteghamati A; Nakhjavani M
Diabetes Res Clin Pract; 2017 Nov; 133():131-141. PubMed ID: 28934670
[TBL] [Abstract][Full Text] [Related]
14. Effects of the glucose-lowering rate on cTnI and hs-CRP serum levels in type 2 diabetics.
Wu W; Li Q; Xia J; Wang M; Sun Z; Miao J; Zheng Z
Hum Immunol; 2013 Mar; 74(3):379-82. PubMed ID: 23220502
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of ultrasensitive CRP and microalbuminuria as cardiovascular risk markers in type 2 diabetic moroccan patients.
El Boukhrissi F; Benbella I; Ouleghzal H; Safi S; Bamou Y; Balouch L
Tunis Med; 2017 Novembre; 95(11):982-987. PubMed ID: 29877557
[TBL] [Abstract][Full Text] [Related]
16. Importance of hematological parameters for micro- and macrovascular outcomes in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study.
Cardoso CRL; Leite NC; Salles GF
Cardiovasc Diabetol; 2021 Jul; 20(1):133. PubMed ID: 34229668
[TBL] [Abstract][Full Text] [Related]
17. High-sensitivity C reactive protein and risk of cardiovascular disease in China-CVD study.
Dong Y; Wang X; Zhang L; Chen Z; Zheng C; Wang J; Kang Y; Shao L; Tian Y; Wang Z;
J Epidemiol Community Health; 2019 Feb; 73(2):188-192. PubMed ID: 30530521
[TBL] [Abstract][Full Text] [Related]
18. The Synergic Association of hs-CRP and Serum Amyloid P Component in Predicting All-Cause Mortality in Patients With Type 2 Diabetes.
Scarale MG; Copetti M; Garofolo M; Fontana A; Salvemini L; De Cosmo S; Lamacchia O; Penno G; Trischitta V; Menzaghi C
Diabetes Care; 2020 May; 43(5):1025-1032. PubMed ID: 32144164
[TBL] [Abstract][Full Text] [Related]
19. Association between microfibrillar-associated protein 4 (MFAP4) and micro- and macrovascular complications in long-term type 1 diabetes mellitus.
Blindbæk SL; Schlosser A; Green A; Holmskov U; Sorensen GL; Grauslund J
Acta Diabetol; 2017 Apr; 54(4):367-372. PubMed ID: 28039584
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of Highly Sensitive Troponin as a Predictor of Short-Term Outcome in Patients With Diabetes Mellitus and Stable Coronary Artery Disease (from the ARTEMIS Study).
Lepojärvi ES; Piira OP; Kiviniemi AM; Miettinen JA; Kenttä T; Ukkola O; Tulppo MP; Huikuri HV; Junttila MJ
Am J Cardiol; 2016 Feb; 117(4):515-521. PubMed ID: 26739392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
